重度主动脉瓣狭窄合并二尖瓣反流的诊断与管理
重度主动脉瓣狭窄(AS)与二尖瓣反流(MR)常共存,部分观察性研究报告中度或重度MR与更高死亡率相关,但最佳管理仍不明确。同期行主动脉瓣与二尖瓣置换与显著更高的并发症和死亡率相关;经导管或微创治疗允许分期手术,先完成SAVR/TAVR后再评估MR严重程度。现有证据提示部分患者SAVR或TAVR后MR严重程度改善,取决于MR病因、TAVR瓣膜类型、房颤有无、残余主动脉瓣反流等因素;因缺乏随机临床试验,尚无法给出循证推荐。
要点
- 重度AS合并MR常见,中度或重度MR与更高死亡率相关,但最佳管理不明确。
- 同期双瓣置换并发症和死亡率显著更高,可考虑先SAVR/TAVR再评估MR的分期策略。
- SAVR/TAVR后部分患者MR改善,取决于病因、TAVR瓣膜类型、房颤、残余反流等因素。
核心结论
- 重度AS合并MR的最佳管理尚不明确,缺乏随机临床试验证据支持在SAVR或TAVR同期处理MR的循证推荐。
- 同期主动脉瓣与二尖瓣置换与显著更高的并发症和死亡率相关,支持考虑分期手术策略。
研究设计与样本
- 本文为综述,报告并批判性评价该主题现有数据以帮助临床决策。
主要发现
- 部分观察性研究报告中度或重度MR与更高死亡率相关。
- 同期置换主动脉瓣与二尖瓣与显著更高的并发症和死亡率相关。
- SAVR或TAVR后部分患者MR严重程度改善,取决于MR病因、TAVR瓣膜类型、房颤有无、残余主动脉瓣反流等因素。
关键数值与推荐
- 现有证据提示部分患者SAVR或TAVR后MR严重程度改善,但无随机临床试验支持同期处理MR的循证推荐。
临床怎么用
- 建议仔细评估患者并运用临床判断,区分可能从双瓣干预获益者与应仅处理主动脉瓣者。
- 可考虑先完成SAVR或TAVR,再重新评估MR严重程度以决定是否分期干预。
局限性
- 缺乏随机临床试验,无法给出循证推荐。
- 现有证据多来自观察性研究,存在选择偏倚等局限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Severe aortic stenosis (AS) and mitral regurgitation (MR) frequently coexist. Although some observational studies have reported that moderate or severe MR is associated with higher mortality, the optimal management of such patients is still unclear. Simultaneous replacement of both aortic and mitral valves is linked to significantly higher morbidity and mortality. Recent advances in minimally invasive surgical or transcatheter therapies for MR allow for staged procedures in which surgical or transcatheter aortic valve replacement (SAVR/TAVR) is done first and MR severity re-evaluated afterwards. Current evidence suggests MR severity improves in some patients after SAVR or TAVR, depending on several factors (MR aetiology, type of valve used for TAVR, presence/absence of atrial fibrillation, residual aortic regurgitation, etc). However, as of today, the absence of randomised clinical trials does not allow for evidence-based recommendations about whether or not MR should be addressed at the time of SAVR or TAVR. A careful patient evaluation and clinical judgement are recommended to distinguish patients who might benefit from a double valve intervention from those in which MR should be left alone. The aim of this review is to report and critique the available data on this subject in order to help guide the clinical decision making in this challenging subset of patients.
引用
- Sannino A, Grayburn PA. Mitral regurgitation in patients with severe aortic stenosis: diagnosis and management. Heart. 2017. PMID: 28903993. doi:10.1136/heartjnl-2017-311552
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。